Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
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
mUf9NTb8qg9twVmj
